(Q40407383)

20 September 2017

title

p300 regulates p63 transcriptional activity (English)

1 reference

20 September 2017

Mary MacPartlin

1

1 reference

20 September 2017

Shelya Zeng

2

1 reference

20 September 2017

Hunjoo Lee

3

1 reference

20 September 2017

Daniel Stauffer

4

1 reference

20 September 2017

Yetao Jin

5

1 reference

20 September 2017

Mathew Thayer

6

1 reference

20 September 2017

Hua Lu

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

17 June 2005

1 reference

Journal of Biological Chemistry

20 September 2017

published in

1 reference

20 September 2017

volume

280

1 reference

20 September 2017

issue

34

1 reference

20 September 2017

page(s)

30604-30610

1 reference

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

SSRP1 functions as a co-activator of the transcriptional activator p63

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

The p53 and Mdm2 families in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Phosphorylated CREB binds specifically to the nuclear protein CBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Nuclear protein CBP is a coactivator for the transcription factor CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Recruitment of p300/CBP in p53-dependent signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Synergistic activation of transcription by CBP and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Binding and modulation of p53 by p300/CBP coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

The transcriptional coactivators p300 and CBP are histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

The CBP co-activator is a histone acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p300/CBP/p53 interaction and regulation of the p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

DNA damage activates p53 through a phosphorylation-acetylation cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p300 does not require its acetylase activity to stimulate p73 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

A new human p53 homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

MDM2 suppresses p73 function without promoting p73 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

The acetylase activity of p300 is dispensable for MDM2 stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

P63 and P73: P53 mimics, menaces and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

HMG domain proteins: architectural elements in the assembly of nucleoprotein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

The HMG-1 box protein family: classification and functional relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

p63 is the molecular switch for initiation of an epithelial stratification program

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503352200

21 January 2018

Identifiers

DOI

10.1074/JBC.M503352200

1 reference

20 September 2017

1 reference